Cleara Biotech B.V. Alternatives & Competitors

12 companies similar to Cleara Biotech B.V. — Peptide-based clearance of cancer driven by impaired p53

AtG Therapeutics

Overcoming Tumor Adaptation - inhibiting escape mechanisms both in treatment naive and res...

7 Seed $556.00K

Spain

Biotechnology Health Care +1

ProfoundBio

An oncology biotherapeutics company

8 Series B $247.00M

Woodinville, United State...

Biotechnology Health and Wellness

Fresh Wind Biotechnologies

Transforming cancer therapeutics with cutting-edge immunotherapy

2 Series A $10.00M

Houston, United States

Biotechnology Health and Wellness

Ribon Therapeutics

Pioneering Therapeutics Targeting Cellular Stress Pathways

9 Venture round $259.00M

Cambridge, United States

Biotechnology Health Care

Track all Cleara Biotech B.V. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Epitopea

Exploiting a new class of tumour specific antigens for cancer therapy

50 Seed $44.60M

Montreal, Canada

Biotechnology Health and Wellness +1

Cascadian Therapeutics, Inc.

10 Post-IPO Equity $64.90M

Seattle, United States

Biotechnology Health Care +1

Deciduous Therapeutics

Deciduous is developing a novel class of immune-modulatory therapies designed to promote a...

12 Seed $16.50M

San Francisco, United Sta...

Biopharma Biotechnology +1

Arno Therapeutics Inc (ARNI)

3 Post-IPO Equity $61.40M

Biopharma Biotechnology

Lisata Therapeutics, Inc.

Targeted Therapy Delivered

39 Acquired $4.44M

United States

Biotechnology Health and Wellness +1

NEOGAP Therapeutics AB

Science for cure.

28 Grant $147.66M

Stockholm, Sweden

Biotechnology Health Care +1

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and...

26 Post-IPO Equity $262.60M

Foster City, United State...

Biotechnology Health Care +1

Phoenix Molecular Designs

A clinical stage biopharmaceutical company designing precise cancer therapeutics to addres...

22 Series A $12.35M

San Diego, United States

Biotechnology Health Care +1

About Cleara Biotech B.V.

Cleara Biotech B.V., founded in 2018 and headquartered in The Netherlands, operates within the Biotechnology sector, focusing on targeting cellular senescence to extend human healthspan and counteract late-stage cancer. This biopharmaceutical R&D firm specializes in developing therapies for cancer and chronic diseases...

Business keywords

Biopharmaceutical R&D, Therapeutic Development, Cancer Treatment, Senescent Cells, Precision Medicine, Biomarker Development, FOXO4 Program, Cellular Senescence, Chronic Disease Research, Metastatic Cancer Therapy, Molecular Pathways, Innovative Therapeutics, Proprietary Technology, Clinical Development, D-amino Acid Pipeline

Frequently Asked Questions

Companies similar to Cleara Biotech B.V. include AtG Therapeutics, ProfoundBio, Fresh Wind Biotechnologies, Ribon Therapeutics, Epitopea. They work in Biotechnology and share Cleara Biotech B.V.'s focus on cancer treatment, precision medicine and therapeutic development.

Bounce Watch lists 12 companies that share Cleara Biotech B.V.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Cleara Biotech B.V. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Cleara Biotech B.V. Profile AtG Therapeutics Alternatives ProfoundBio Alternatives Fresh Wind Biotechnologies Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Cleara Biotech B.V. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.